CGON
Cg Oncology Inc.

455
Loading...
Loading...
News
all
press releases
Strength Seen in Intellia Therapeutics (NTLA): Can Its 29.8% Jump Turn into More Strength?
Intellia Therapeutics (NTLA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks·20d ago
News Placeholder
More News
News Placeholder
CG Oncology, Inc. (CGON) Moves 5.5% Higher: Will This Strength Last?
CG Oncology, Inc. (CGON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·21d ago
News Placeholder
Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates
Arbutus (ABUS) delivered earnings and revenue surprises of +150.00% and +496.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success
Zacks·5mo ago
News Placeholder
Company News for May 14, 2025
Zacks·5mo ago
News Placeholder
CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates
Zacks·5mo ago
News Placeholder
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates
Zacks·5mo ago
News Placeholder
Malin Announces Profitable CG Oncology Exit
Malin (MLLNF) has released an update. Malin Corporation PLC has successfully sold its entire stake in CG Oncology for approximately 28.5 million...
TipRanks Financial Blog·1y ago
News Placeholder
A Closer Look at 9 Analyst Recommendations For CG Oncology
read more...
Benzinga·1y ago
News Placeholder
Decoding 10 Analyst Evaluations For CG Oncology
read more...
Benzinga·1y ago

Latest CGON News

View

Advertisement|Remove ads.

Advertisement|Remove ads.